Improvement of Live Babies Rates After ICSI, Using cpFT (NCT04954274) | Clinical Trial Compass
Active — Not RecruitingPhase 3
Improvement of Live Babies Rates After ICSI, Using cpFT
France366 participantsStarted 2021-07-29
Plain-language summary
Demonstrate the improvement of the live births rate after ICSI by supplementing the pre-ICSI incubation medium of oocytes and that of preimplantation embryos with cpFT at the 1st embryo transfer for women under 37 years old.
Who can participate
Age range18 Years – 36 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Couples eligible for a attempt at Assisted Reproduction (AMP).
* Couples asking for Assisted Reproductive Technology, and requiring an ICS procedure.
* Women aged 18 to 36 inclusive.
* Men aged 18 to 58 inclusive
* Use of CSCM-C culture medium from Biocare / Irvine, exclusively.
* People affiliated to a Social Security scheme
Exclusion Criteria:
* Lack of consent
* Early menopause.
* Couples under IVF or Intra Uterine Insemination treatment.
* People unable to follow protocol visits in France.
* Couple with a contraindication to treatment with ART.
* Women with a contraindication to treatment with ART or an associated pathology such as: hypertension, risk of eclampsia, family genetic problems, diabetes, uterine partitions, synechiae adhesions, adenomyosis or any other contraindication judged as such by the investigator.
* ART with donation of gametes or embryos.
* Participant under guardianship or guardianship
What they're measuring
1
Live birth rate after the first embryo transfer
Timeframe: 54 months after the first randomization